This inventor holds 1 USPTO granted patent. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Patrick Weynants: Innovator in Cancer Research
Introduction
Patrick Weynants is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly in the diagnosis of lung adenocarcinomas. His innovative methods have the potential to improve patient outcomes through early detection.
Latest Patents
Weynants holds a patent for a method that determines lung adenocarcinomas by assaying for the expression of genes coding for tumor rejection antigen precursors MAGE-1, 2, and 3, or their expression products. This patent represents a crucial advancement in the diagnostic techniques available for lung cancer.
Career Highlights
Patrick Weynants is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to work on groundbreaking research in oncology. His dedication to improving cancer diagnostics has positioned him as a key figure in the field.
Collaborations
Weynants has collaborated with esteemed colleagues such as Thierry R Boon-Falleur and Bernard Lethe. These partnerships have fostered a collaborative environment that enhances the research and development of innovative cancer treatments.
Conclusion
Patrick Weynants is a prominent inventor whose work in cancer research is paving the way for advancements in diagnostic methods. His contributions are vital to the ongoing fight against lung cancer, and his innovative spirit continues to inspire others in the field.